Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesOther interest incomePreferred Dividend PaymentsProfit After TaxProvisionsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ACRES Commercial Realty (ACR-PC) Other interest income (2016 - 2025)

ACRES Commercial Realty has reported Other interest income over the past 16 years, most recently at $233000.0 for Q3 2025.

  • Quarterly results put Other interest income at $233000.0 for Q3 2025, down 60.44% from a year ago — trailing twelve months through Sep 2025 was $1.2 million (down 59.79% YoY), and the annual figure for FY2024 was $2.4 million, down 23.37%.
  • Other interest income for Q3 2025 was $233000.0 at ACRES Commercial Realty, down from $334000.0 in the prior quarter.
  • Over the last five years, Other interest income for ACR-PC hit a ceiling of $859000.0 in Q1 2023 and a floor of $13000.0 in Q1 2021.
  • Median Other interest income over the past 5 years was $334000.0 (2025), compared with a mean of $378315.8.
  • Biggest five-year swings in Other interest income: plummeted 87.0% in 2021 and later soared 4421.05% in 2023.
  • ACRES Commercial Realty's Other interest income stood at $24000.0 in 2021, then soared by 1783.33% to $452000.0 in 2022, then soared by 84.73% to $835000.0 in 2023, then tumbled by 59.28% to $340000.0 in 2024, then plummeted by 31.47% to $233000.0 in 2025.
  • The last three reported values for Other interest income were $233000.0 (Q3 2025), $334000.0 (Q2 2025), and $257000.0 (Q1 2025) per Business Quant data.